Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gregg Stone and Ajay Kirtane.
Gregg Stone
Connection Strength
5.008
Ajay Kirtane
  1. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents. Circ Cardiovasc Interv. 2018 11; 11(11):e006243.
    View in: PubMed
    Score: 0.198
  2. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. Int J Cardiol. 2018 Oct 01; 268:61-67.
    View in: PubMed
    Score: 0.197
  3. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
    View in: PubMed
    Score: 0.197
  4. Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents. Am Heart J. 2018 11; 205:77-86.
    View in: PubMed
    Score: 0.195
  5. Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study. EuroIntervention. 2018 Jul 20; 14(4):e459-e466.
    View in: PubMed
    Score: 0.194
  6. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. JACC Cardiovasc Interv. 2018 07 09; 11(13):1277-1286.
    View in: PubMed
    Score: 0.193
  7. Bleeding Severity After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2018 03; 11(3):e005542.
    View in: PubMed
    Score: 0.189
  8. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study. Am Heart J. 2018 03; 197:142-149.
    View in: PubMed
    Score: 0.186
  9. Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Int J Cardiol. 2017 Nov 01; 246:20-25.
    View in: PubMed
    Score: 0.185
  10. Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. J Am Coll Cardiol. 2017 Oct 10; 70(15):1846-1857.
    View in: PubMed
    Score: 0.184
  11. Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. Int J Cardiol. 2018 Jan 01; 250:92-97.
    View in: PubMed
    Score: 0.184
  12. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care. 2018 Jun; 7(4):339-347.
    View in: PubMed
    Score: 0.183
  13. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). Am J Cardiol. 2017 Sep 15; 120(6):917-923.
    View in: PubMed
    Score: 0.181
  14. A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations. J Am Coll Cardiol. 2017 Jun 06; 69(22):2748-2758.
    View in: PubMed
    Score: 0.180
  15. Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial. JAMA Cardiol. 2017 06 01; 2(6):673-677.
    View in: PubMed
    Score: 0.180
  16. Percutaneous Coronary Intervention of Saphenous Vein Graft. Circ Cardiovasc Interv. 2017 May; 10(5).
    View in: PubMed
    Score: 0.179
  17. Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup. J Am Coll Cardiol. 2017 03 21; 69(11):1517-1518.
    View in: PubMed
    Score: 0.177
  18. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Circ Cardiovasc Interv. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.177
  19. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Circ Cardiovasc Interv. 2017 02; 10(2).
    View in: PubMed
    Score: 0.176
  20. Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. J Am Coll Cardiol. 2017 01 24; 69(3):364-365.
    View in: PubMed
    Score: 0.175
  21. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol. 2017 Mar 15; 231:61-67.
    View in: PubMed
    Score: 0.174
  22. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes. JACC Cardiovasc Interv. 2013 Jan; 6(1):36-43.
    View in: PubMed
    Score: 0.132
  23. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
    View in: PubMed
    Score: 0.059
  24. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141.
    View in: PubMed
    Score: 0.059
  25. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
    View in: PubMed
    Score: 0.058
  26. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. 2021 02 26; 12(1):1325.
    View in: PubMed
    Score: 0.058
  27. Extrapulmonary manifestations of COVID-19. Nat Med. 2020 07; 26(7):1017-1032.
    View in: PubMed
    Score: 0.056
  28. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 05 12; 75(18):2352-2371.
    View in: PubMed
    Score: 0.055
  29. Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention. EuroIntervention. 2019 08 09; 15(6):e551-e557.
    View in: PubMed
    Score: 0.052
  30. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery. Coron Artery Dis. 2019 08; 30(5):346-351.
    View in: PubMed
    Score: 0.052
  31. Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study. Catheter Cardiovasc Interv. 2018 11 01; 92(5):E348-E355.
    View in: PubMed
    Score: 0.048
  32. Morphological Patterns of In-Stent Chronic Total Occlusions: An Intravascular Ultrasound Study. JACC Cardiovasc Interv. 2018 04 09; 11(7):711-714.
    View in: PubMed
    Score: 0.048
  33. Mechanisms of Orbital Versus Rotational Atherectomy Plaque Modification in Severely Calcified Lesions Assessed by Optical Coherence Tomography. JACC Cardiovasc Interv. 2017 12 26; 10(24):2584-2586.
    View in: PubMed
    Score: 0.047
  34. Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy. Int J Cardiol. 2017 Dec 01; 248:97-102.
    View in: PubMed
    Score: 0.046
  35. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
    View in: PubMed
    Score: 0.045
  36. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. J Invasive Cardiol. 2017 Nov; 29(11):378-386.
    View in: PubMed
    Score: 0.045
  37. Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy. Coron Artery Dis. 2017 May; 28(3):218-224.
    View in: PubMed
    Score: 0.045
  38. Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. J Invasive Cardiol. 2017 Apr; 29(4):123-131.
    View in: PubMed
    Score: 0.044
  39. An Updated Protocol for Evaluating Chest Pain and Managing Acute Coronary Syndromes. Crit Pathw Cardiol. 2017 03; 16(1):7-14.
    View in: PubMed
    Score: 0.044
  40. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study. JACC Cardiovasc Interv. 2017 01 23; 10(2):147-156.
    View in: PubMed
    Score: 0.044
  41. Outcomes of a Combined Approach of Percutaneous Coronary Revascularization and Cardiac Valve Surgery. Innovations (Phila). 2017 Jan/Feb; 12(1):4-8.
    View in: PubMed
    Score: 0.044
  42. Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy. J Am Heart Assoc. 2016 12 22; 5(12).
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.